RCT of Post-Suicide Attempt Case Management (ACTION-J) (ACTION-J)
A Randomized Controlled Multicenter Trial of Post-Suicide Attempt Case Management for the Prevention of Further Attempts in Japan (ACTION-J)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
-
Fukuoka, Japan, 814-0128
- Fukuoka University Hospital
-
Osaka, Japan
- National Hospital Organization, Osaka Medical Center
-
Tokyo, Japan, 113-0022
- Nihon Medical University Hospital
-
Tokyo, Japan, 142-0064
- Showa University Hospital
-
-
Aichi
-
Toyoake, Aichi, Japan, 470-1192
- Fujita Health University Hospital
-
-
Ibaraki
-
Mito, Ibaraki, Japan, 311-3198
- National Hospital Organization, Mito Medical Center
-
Tsuchiura, Ibaraki, Japan, 300-0053
- Tsuchiura Kyodo Hospital
-
Tsukuba, Ibaraki, Japan, 305-8558
- Tsukuba Medical Center
-
-
Iwate
-
Morioka, Iwate, Japan, 020-0023
- Iwate Medical University Hospital
-
-
Kanagawa
-
Sagamihara, Kanagawa, Japan, 228-0829
- Kitazato University Hospital
-
Yokohama, Kanagawa, Japan, 232-0024
- Yokohama City University Medical Center
-
-
Nara
-
Kashihara, Nara, Japan, 634-0813
- Nara Medical University Hospital
-
-
Oita
-
Beppu, Oita, Japan, 874-8585
- Oita Kouseiren Tsurumi Hospital
-
Yufu, Oita, Japan, 897-5503
- Oita University Hospital
-
-
Osaka
-
Moriguchi, Osaka, Japan, 570-0074
- Kansai Medical University Takii Hospital
-
Sayama, Osaka, Japan, 589-0014
- Kinki University Hospital
-
-
Saitama
-
Kawagoe, Saitama, Japan, 350-8550
- Saitama Medical University Medical Center
-
Moroyama, Saitama, Japan, 350-0495
- Saitama Medical University Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Over 20 years old
- Suffering from Axis I disorder
- Had intent for suicide (confirmed more than 2 times)
- Able to understand this study and provide informed consent
- Able to have interview before trial registry and psycho education at hospital
- Able to have interview for assessment at continuous follow-up care by case manager at the hospital
Exclusion Criteria:
- Not suffering from Axis I disorder as a primary diagnosis
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
EXPERIMENTAL: Case management
|
Case management, Usual clinical practice and Providing paper based information for suicide prevention
|
|
ACTIVE_COMPARATOR: Enhanced usual care
|
Usual clinical practice and Providing paper based information for suicide prevention
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
First recurrent suicide behavior (suicide attempted and completed suicide)
Time Frame: Minimum 1.5 year
|
Minimum 1.5 year
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Any cause of death
Time Frame: Minimum 1.5 year
|
Minimum 1.5 year
|
|
Repeated recurrent incidence of suicide attempts
Time Frame: Minimum 1.5 year
|
Minimum 1.5 year
|
|
Utilization or personal or social resources
Time Frame: Minimum 1.5 year
|
Minimum 1.5 year
|
|
Number of self-injury
Time Frame: Minimum 1.5 year
|
Minimum 1.5 year
|
|
Health care utilization
Time Frame: Minimum 1.5 year
|
Minimum 1.5 year
|
|
Physical function
Time Frame: Minimum 1.5 year
|
Minimum 1.5 year
|
|
Beck hopeless scale
Time Frame: Minimum 1.5 year
|
Minimum 1.5 year
|
|
SF-36
Time Frame: Minimum 1.5 year
|
Minimum 1.5 year
|
|
Adverse events
Time Frame: Minimum 1.5 year
|
Minimum 1.5 year
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Incidence proportion of the first episode of recurrent suicidal behaviour (attempted suicide or completed suicide)
Time Frame: at 1 month after the randomization
|
at 1 month after the randomization
|
|
Incidence proportion of the first episode of recurrent suicidal behaviour (attempted suicide or completed suicide)
Time Frame: at 3 months after the randomization
|
at 3 months after the randomization
|
|
Incidence proportion of the first episode of recurrent suicidal behaviour (attempted suicide or completed suicide)
Time Frame: at 6 months after the randomization
|
at 6 months after the randomization
|
|
Incidence proportion of the first episode of recurrent suicidal behaviour (attempted suicide or completed suicide)
Time Frame: at 12 months after the randomization
|
at 12 months after the randomization
|
|
Incidence proportion of the first episode of recurrent suicidal behaviour (attempted suicide or completed suicide)
Time Frame: at 18 months after the randomization
|
at 18 months after the randomization
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Yoshio Hirayasu, MD,PhD, Yokohama city university
Publications and helpful links
General Publications
- Storebo OJ, Stoffers-Winterling JM, Vollm BA, Kongerslev MT, Mattivi JT, Jorgensen MS, Faltinsen E, Todorovac A, Sales CP, Callesen HE, Lieb K, Simonsen E. Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev. 2020 May 4;5(5):CD012955. doi: 10.1002/14651858.CD012955.pub2.
- Witt KG, Hetrick SE, Rajaram G, Hazell P, Taylor Salisbury TL, Townsend E, Hawton K. Psychosocial interventions for self-harm in adults. Cochrane Database Syst Rev. 2021 Apr 22;4(4):CD013668. doi: 10.1002/14651858.CD013668.pub2.
- Hirayasu Y, Kawanishi C, Yonemoto N, Ishizuka N, Okubo Y, Sakai A, Kishimoto T, Miyaoka H, Otsuka K, Kamijo Y, Matsuoka Y, Aruga T. A randomized controlled multicenter trial of post-suicide attempt case management for the prevention of further attempts in Japan (ACTION-J). BMC Public Health. 2009 Sep 26;9:364. doi: 10.1186/1471-2458-9-364.
- Kawanishi C, Hirayasu Y, Ariga T, Ishizuka N, Yamada M, Takahashi K. ["ACTION-J", a multi-center joint study for the development of strategies to prevent recurrence of suicidal ideation (a strategic study for anti-suicide policies supported by the Health, Labor and Welfare Ministry): its background and research outline]. Seishin Shinkeigaku Zasshi. 2008;110(3):230-7. No abstract available. Japanese.
- Inui-Yukawa M, Miyaoka H, Yamamoto K, Kamijo Y, Takai M, Yonemoto N, Kawanishi C, Otsuka K, Tachikawa H, Hirayasu Y. Effectiveness of assertive case management for patients with suicidal intent. Psychiatry Res. 2021 Oct;304:114125. doi: 10.1016/j.psychres.2021.114125. Epub 2021 Jul 19.
- Kawanishi C, Aruga T, Ishizuka N, Yonemoto N, Otsuka K, Kamijo Y, Okubo Y, Ikeshita K, Sakai A, Miyaoka H, Hitomi Y, Iwakuma A, Kinoshita T, Akiyoshi J, Horikawa N, Hirotsune H, Eto N, Iwata N, Kohno M, Iwanami A, Mimura M, Asada T, Hirayasu Y; ACTION-J Group. Assertive case management versus enhanced usual care for people with mental health problems who had attempted suicide and were admitted to hospital emergency departments in Japan (ACTION-J): a multicentre, randomised controlled trial. Lancet Psychiatry. 2014 Aug;1(3):193-201. doi: 10.1016/S2215-0366(14)70259-7. Epub 2014 Aug 5.
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
First Posted
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- J-MISP-01
- C000000444 (REGISTRY: UMIN-CTR)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.